publicações selecionadas
-
artigo académico
- Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT1A receptor biased agonist. Biomedicine & Pharmacotherapy. 2025
- Loss of egli-1, the Caenorhabditis elegans Orthologue of a Downstream Target of SMN, Leads to Abnormalities in Sensorimotor Integration. Molecular Neurobiology. 2020
- Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease. Molecular Neurobiology. 2019
- Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease. Brain. 2015
-
documento
- Therapeutic efficacy of chronic 5-HT1A receptor agonism by befiradol in Spinocerebellar Ataxia Type 3 mice 2024
- Serotonergic signaling modulation as a therapeutic strategy for Machado-Joseph disease: finding the molecular traits 2022
- Can chronic activation of serotonergic signalling be a therapeutic approach for neurodegenerative diseases? 2021
- Can chronic activation of serotonergic signalling be atherapeutic approach for neurodegenerative diseases? 2021
- Does activation of serotonergic treatment suppress proteotoxicity in mouse models of neurodegenerative diseases? 2021
- Serotonergic Signalling Activation as a Therapeutic Approach for Neurodegenerative Diseases 2020
- Serotonergic signaling activation suppresses proteotoxicity 2019
- Finding molecular determinants supporting serotonergic modulation as a therapeutic approach in Machado Joseph Disease 2019
- Early modulation of serotonergic signaling suppresses aggregation in Spinocerebellar Ataxia 3 2019
- Preclinical evidence supporting serotonergic modulation as a therapeutic approach for Spinocerebellar Ataxia 3 2019
- Finding molecular determinants supporting serotonergic modulation as a therapeutic approach in Machado-Joseph disease 2018
- Preclinical evidence supporting early initiation of citalopram treatment in Machado-Joseph disease 2018
- Serotonergic modulation of the proteostasis network and glutamatergic neurotransmission: impact on MJD 2017
- Study of the role of ceramide in acetate-induced cell death in colorectal carcinoma cell lines 2012
- iPSC-derived MSC secretome activates distinct neuroprotective pathways in a preclinical model of Parkinson’s disease